Multiple sclerosis (MS) primarily affects adult females. However, in the last decades, rising
incidence and prevalence have been observed for demographic extremes, such as pediatric …

Objective Multiple sclerosis (MS) is associated with cognitive impairment (CI) such as
slowed information processing speed (IPS). Currently, no immunocellular or molecular …

Cognitive impairment (CI) is a frequent and disabling symptom in Multiple Sclerosis (MS).
Axonal damage may contribute to CI development from early stages. Nevertheless, no …

Nowadays, there is a need for reliable fluid biomarkers to improve differential diagnosis,
prognosis, and the prediction of treatment response, particularly in the management of …

Background and objectives Serum biomarkers are emerging as useful prognostic tools for
multiple sclerosis (MS); however, long-term studies are lacking. We aimed to evaluate the …

Multiple Sclerosis (MS) is a debilitating disease with typical onset between 20 and 40 years
of age, so the disability associated with this disease, unfortunately, occurs in the prime of life …

The cytoskeleton is the main intracellular structure that determines the morphology of
neurons and maintains their integrity. Therefore, disruption of its structure and function may …

Several important questions regarding cognitive aging and dementia in older people with
multiple sclerosis (PwMS) are the focus of this narrative review: Do older PwMS have worse …

miRNAs play an important role in neurodegenerative diseases. Many miRNA-target gene
interactions (MTI) have been experimentally confirmed and associated with Alzheimer's …

Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease characterized by
progressive degeneration of upper and lower motor neurons. The heterogeneous nature of …